Pharmaceutical group · United States

Agios

United States13 medicines4 countries

A group of 3 companies with 13 medicines in 4 countries.

Website Its medicines

Group structure

3 companies in 1 country

United States2

Headquarters not stated1

Agios Netherlands BVAuthorisation holder · 11 medicines · listed in Spain, the EU (EMA) +4

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

13 medicines

Medicine	Substance	Country	Status	Authorised
AQVESME100mg base · Tablet	Mitapivat	United States	Marketed	2022
Pyrukynd	Mitapivat	EU (EMA)	Authorised	2022
PYRUKYND20mg base \| 50mg base \| 5mg base · Tablet	Mitapivat	United States	Marketed	2022
Pyrukynd 100 mg, filmomhulde tablettenFilmomhulde tablet	Mitapivat	Netherlands	Authorised	2022
PYRUKYND 20 MG + 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5,850 mg + 23,40 mg · Comprimido recubierto con película	Mitapivat	Spain	Authorised	2026
PYRUKYND 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA23,40 mg · Comprimido recubierto con película	Mitapivat	Spain	Authorised	2026
Pyrukynd 20 mg, filmomhulde tablettenFilmomhulde tablet	Mitapivat	Netherlands	Authorised	2022
PYRUKYND 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5,850 mg · Comprimido recubierto con película	Mitapivat	Spain	Authorised	2026
Pyrukynd 5 mg, filmomhulde tablettenFilmomhulde tablet	Mitapivat	Netherlands	Authorised	2022
PYRUKYND 50 MG + 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA23,40 mg + 58,50 mg · Comprimido recubierto con película	Mitapivat	Spain	Authorised	2026
PYRUKYND 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA58,50 mg · Comprimido recubierto con película	Mitapivat	Spain	Authorised	2026
Pyrukynd 50 mg, filmomhulde tablettenFilmomhulde tablet	Mitapivat	Netherlands	Authorised	2022
Tibsovo	Ivosidenib	EU (EMA)	Refused

Sources and licences

Country	Medicines	Current	Past	Companies
Spain	5	5	0	Companies All medicines
Netherlands	4	4	0	Companies All medicines
European Union (EMA)	2	1	1	Companies All medicines
United States	2	2	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

All 10 sources

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Läkemedelsverket, Sweden

Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

Wikidata

Wikidata (CC0)

Licence: CC0 1.0

Report an error or request removal Corrections from the company itself are welcome.

Agios

Group structure

United States2

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Agios

Group structure

United States2

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Identifiers

Work with Prognia

Other big groups

United States: more companies

Group structure

🇺🇸United States2

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Group structure

🇺🇸United States2

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Identifiers

Work with Prognia

United States2

United States2